^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
KRAS-EphA-2-CAR-DC
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Chinese PLA General Hospital
Drug class:
Dendritic cell activator, EphA2 inhibitor
Related drugs:
Phase 1
Chinese PLA General Hospital
Recruiting
Last update posted :
02/06/2024
Initiation :
04/03/2023
Primary completion :
12/30/2025
Completion :
12/30/2026
KRAS
|
PD-L1 expression • KRAS mutation • MSI-H/dMMR • KRAS G12C • KRAS G12D • KRAS G12V • KRAS G12
|
Yervoy (ipilimumab) • albumin-bound paclitaxel • cyclophosphamide • KRAS-EphA-2-CAR-DC
Share
